A Proof-of-Concept Study Assessing NEO6860 in Osteoarthritis Pain
Status:
Completed
Trial end date:
2016-11-24
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess NEO6860, a modality selective TRPV1 antagonist, in
patients with pain associated with osteoarthritis of the knee.